About Index Trending news
Analyze
Top 50 Pricing
Vaximm

Vaximm

Vaximm

Vaximm, a vaccine company based in Switzerland developing immunotherapies for cancer patients, offers VXM01 targeting tumor vasculature.

Elsewhere

Alexa global traffic share

Latest funding
Venture capital
$8,000,000
Employees

Unknown size

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Vaximm makes some noise.